Accu-Chek® CONNECT at School (CATS) Pediatric Study

NACompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

December 28, 2015

Primary Completion Date

January 20, 2017

Study Completion Date

January 20, 2017

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

Accu-Chek® CONNECT DMS

SMBG will be performed during the 6-month study using the Accu-Chek® Aviva CONNECT monitoring device, and corresponding Smartphone app and online tracking tool.

DEVICE

DMS

SMBG will be performed during the 6-month study according to usual care, using the participant's current DMS (other than Accu-Chek® CONNECT DMS).

Trial Locations (13)

14222

Women and Children's Hospital of Buffalo, Buffalo

27834

East Caroline University - Pediatric specialty Care, Greenville

30342

Pediatric Endocrine Associates, Atlanta

32308

Tallahassee Memorial Hospital, Tallahassee

32504

Nemours Childrens Hospital, Pensacola

33612

University of South Florida College of Medicine, Tampa

46032

Indiana University Riley, Carmel

55102

Childrens Hospital and Clinics of Minnesota, Saint Paul

60453

Advocate Center for Pediatric Research, Oak Lawn

80045

Barbara Davis Center for Childhood Diabetes, Aurora

83404

Rocky Mountain Diabetes & Osteoporosis Center, Idaho Falls

85053

Pediatric Endocrinology of Phoenix, Phoenix

95821

Center of Excellence in Diabetes and Endocrinology, Sacramento

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02609633 - Accu-Chek® CONNECT at School (CATS) Pediatric Study | Biotech Hunter | Biotech Hunter